Žaloudík J, Skovajsová M, Česlarová K, Bieberová L, Hussarová L, Zimovjanová M, Petruželka L
Klin Onkol. 2013;26(6):443-7.
In the Czech Republic bone scintigraphy has still been performed routinely as a part of preoperative staging examinations of early breast carcinomas, which had been in 42% diagnosed in the national breast cancer screening program. The incidence of synchronnous distant metastases was analysed for a subgroup of T1N0 breast carcinomas using the database of the Czech National Cancer Registry. Out of 21,675 women with T1N0 breast carcinomas diagnosed in the decade of 2001-2010 the potential occurence of various distant metastases (M1) was estimated in 147 cases (0,68%). Since only approximately 40% of all distant metastases were skeletal (M1 OSS), the pro-bability of bone metastases in T1N0 breast cancer does not exceed 0,3-0,4%. Distant metastases were present in 0,5% in a subgroup of well and moderately differentiated carcinomas and up to 1,2% in poorly differentiated and anaplastic tumors, however, only a minor part (0,2% and 0,5%, respectively) involved bones. We conclude that preoperative bone scintigraphy is overused and undue in more than 99% of Czech women with early breast cancer T1N0. Skeletal scintigraphy as a staging procedure for small breast carcinoma T1N0 may perhaps be recommended only postoperatively and very selectively with regards to individual risk factors and symptomatology.
在捷克共和国,骨闪烁显像术仍作为早期乳腺癌术前分期检查的一部分常规进行,其中42%的病例是在国家乳腺癌筛查项目中确诊的。利用捷克国家癌症登记处的数据库,对T1N0期乳腺癌亚组的同步远处转移发生率进行了分析。在2001年至2010年这十年间确诊的21675例T1N0期乳腺癌女性中,估计有147例(0.68%)可能发生各种远处转移(M1)。由于所有远处转移中只有约40%是骨转移(M1 OSS),T1N0期乳腺癌发生骨转移的概率不超过0.3 - 0.4%。在高分化和中分化癌亚组中,远处转移发生率为0.5%,在低分化和间变性肿瘤亚组中高达1.2%,然而,只有一小部分(分别为0.2%和0.5%)涉及骨骼。我们得出结论,在超过99%的捷克T1N0期早期乳腺癌女性中,术前骨闪烁显像术被过度使用且不合理。对于T1N0期小乳腺癌,骨闪烁显像作为一种分期检查方法,或许仅在术后且根据个体危险因素和症状非常有选择性地推荐使用。